Association between use of sodium-glucose cotransporter 2 inhibitors, glucagon-like peptide 1 agonists, and dipeptidyl peptidase 4 inhibitors with all-cause mortality in patients with type 2 diabetes: A systematic review and Meta-analysis - Zheng, S L; Roddick, A J; Aghar-Jaffar, R (JAMA, 2018)
et al.